Citation: | QIN Suping. Research on levels of C reactive protein and homocysteine in elderly patients with dementia[J]. Journal of Clinical Medicine in Practice, 2020, 24(11): 56-58. DOI: 10.7619/jcmp.202011015 |
Vishnu V Y, Modi M, Garg V K, et al. Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia-A pilot study from a tertiary center in Northern India[J]. Asian J Psychiatr, 2017, 29: 59-62.
|
Cipollini V, Troili F, Giubilei F. Emerging biomarkers in vascular cognitive impairment and dementia: from pathophysiological pathways to clinical application[J]. Int J Mol Sci, 2019, 20(11): E2812-E2818.
|
Birkenhäger W H, Staessen J A. Convergence of atherosclerosis and Alzheimer's disease[J]. Lancet, 2004, 363(9426): 2091-2097.
|
Morgan A R, Touchard S, Leckey C, et al. Inflammatory biomarkers in Alzheimer's disease plasma[J]. Alzheimers Dement, 2019, 15(6): 776-787.
|
Lehmann D J, Cortina-Borja M. Genetic influence of plasma homocysteine on Alzheimer's disease[J]. Neurobiol Aging, 2019, 76: 217-218.
|
Nilsson K, Gustafson L, Hultberg B. C-reactive protein level is decreased in patients with Alzheimer's disease and related to cognitive function and survival time[J]. Clin Biochem, 2011, 44(14/15): 1205-1208.
|
Strang F, Scheichl A, Chen Y C, et al. Amyloid plaques dissociate pentameric to monomeric C-reactive protein: a novel pathomechanism driving cortical inflammation in Alzheimer's disease[J]. Brain Pathol, 2012, 22(3): 337-346.
|
Hsu P F, Pan W H, Yip B S, et al. C-reactive protein predicts incidence of dementia in an elderly Asian community cohort[J]. J Am Med Dir Assoc, 2017, 18(3): 277-288.
|
Ray L, Khemka V K, Behera P, et al. Serum homocysteine, dehydroepiandrosterone sulphate and lipoprotein(a)in Alzheimer's disease and vascular dementia[J]. Aging Dis, 2013, 4(2): 57-64.
|
Cervellati C, Romani A, Seripa D, et al. Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia[J]. J Neurol Sci, 2014, 337(1/2): 156-161.
|
1. |
王小雯,郭丽纳,王会敏,郭海星,石文博. 基于早期肺部CT定量检测评估中重度ARDS患者预后的价值. 中国CT和MRI杂志. 2025(03): 56-58 .
![]() | |
2. |
曾渊杰,宋晓龙,薛寅. 大柴胡汤加减辅助治疗急性胰腺炎(腑实热结证)的临床观察. 中国中医急症. 2025(03): 491-494 .
![]() | |
3. |
刘艳,帅玉婷,涂娇子,刘云,应志兰. 股动脉ECMO辅助治疗冠状动脉旁路移植术后患者预后不良的危险因素. 检验医学与临床. 2024(05): 707-711 .
![]() | |
4. |
张方,王娜,孟君,赵智东,崔存晓,任成波. 肺泡灌洗液病原微生物宏基因二代测序技术在难治性肺炎治疗中的应用效果. 保健医学研究与实践. 2024(04): 78-83 .
![]() | |
5. |
叶青,田瑞雪,侯洪颜,颜卫峰. 经鼻高流量氧疗对稳定期慢性阻塞性肺疾病合并高碳酸血症的疗效分析. 实用临床医药杂志. 2024(14): 67-71+76 .
![]() | |
6. |
施静,潘溢丹. 慢性阻塞性肺疾病急性加重患者高分辨率CT肺血管参数与肺功能、病情严重程度及预后相关性分析. 陕西医学杂志. 2024(12): 1649-1653 .
![]() | |
7. |
胡建粤. 无创呼吸机联合氧驱动雾化吸入治疗慢性阻塞性肺病急性加重患者的疗效分析. 实用中西医结合临床. 2024(21): 46-49 .
![]() | |
8. |
周晓兰,杨楠,温海娟,刘秀云,罗雪娇,武彦锋,刘岩峰,李岩. 基于临床特征、实验室指标分析多重耐药鲍曼不动杆菌感染重症肺炎患者预后不良的危险因素. 中国临床医生杂志. 2024(12): 1426-1429 .
![]() | |
9. |
龚建,焦宪法. 重症监护室脓毒症休克患者进行山莨菪碱治疗的临床观察. 深圳中西医结合杂志. 2024(24): 120-123 .
![]() |